Neurocrine Biosciences | Kapitalizacja Rynkowa



Market Capitalization Zmiana Data
AbbVie USD 350.71B 19.93B 2025-05
Agios Pharmaceuticals USD 1.72B 21M 2025-05
ALKERMES USD 5.14B 301M 2025-05
Alnylam Pharmaceuticals USD 33.46B 1.67B 2025-05
Amgen USD 150.93B 16.57B 2025-05
Biogen USD 17.99B 2.04B 2025-05
BioMarin Pharmaceutical USD 11.82B 1.73B 2025-05
Cytokinetics USD 5.55B 661M 2024-12
Dynavax Technologies USD 1.68B 219M 2024-12
Gilead Sciences USD 129.47B 10.21B 2025-05
Halozyme Therapeutics USD 6.08B 1.17B 2024-12
Incyte USD 14.08B 2.36B 2025-05
Ionis Pharmaceuticals USD 4.78B 14M 2025-05
Neurocrine Biosciences USD 10.91B 2.91B 2025-05
Pfizer USD 137.09B 6.62B 2025-05
Prothena USD 745M 155M 2024-12
Regeneron Pharmaceuticals USD 66.6B 2.74B 2025-05
Repligen USD 7.85B 699M 2025-05
Sarepta Therapeutics USD 11.78B 128M 2024-12
Teva Pharmaceutical Industries ILS 91.91B 16.81B 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
Vertex Pharmaceuticals USD 130.09B 26.64B 2025-05



Neurocrine Biosciences Kapitalizacja Rynkowa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.